 | Up a level |
Choy, Ernest H; Bernasconi, Corrado Angelo; Aassi, Maher; Molina, Jose Fernando; Epis, Oscar Massimiliano (2017). Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic in a Global Comparative Observational Study. Arthritis care & research, 69(10), pp. 1484-1494. Wiley-Blackwell 10.1002/acr.23303
Dougados, Maxime; Huizinga, Tom W J; Choy, Ernest H; Bingham, Clifton O; Aassi, Maher; Bernasconi, Corrado Angelo (2015). Evaluation of the Disease Activity Score in Twenty-Eight Joints-Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial. Arthritis care & research, 67(12), pp. 1762-1766. Wiley-Blackwell 10.1002/acr.22633
Bykerk, Vivian P; Östör, Andrew J K; Alvaro-Gracia, José; Pavelka, Karel; Román Ivorra, José Andrés; Graninger, Winfried; Bensen, William; Nurmohamed, Michael T; Krause, Andreas; Bernasconi, Corrado Angelo; Aassi, Maher; Sibilia, Jean (2015). Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical rheumatology, 34(3), pp. 563-571. Springer 10.1007/s10067-014-2857-y
Huizinga, T W J; Conaghan, Philip G; Martin-Mola, Emilio; Schett, Georg; Amital, Howard; Xavier, Ricardo M; Troum, Orrin; Aassi, Maher; Bernasconi, Corrado Angelo; Dougados, Maxime (2014). Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. Annals of the rheumatic diseases, 74(1), pp. 35-43. BMJ Publishing Group 10.1136/annrheumdis-2014-205752
